Connection

David Mahvi to Survival Rate

Back to Details
This is a "connection" page, showing publications David Mahvi has written about Survival Rate.
David Mahvi
Connection Strength
0.086
Survival Rate
  1. Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma. Cancer Immunol Immunother. 2018 Oct; 67(10):1647-1658.
    View in: PubMed
    Score: 0.031
  2. Diagnosis and management of retroperitoneal soft-tissue sarcoma. Ann Surg. 1991 Jul; 214(1):2-10.
    View in: PubMed
    Score: 0.019
  3. Impact of selection bias on the utilization of adjuvant therapy for pancreas adenocarcinoma. Ann Surg Oncol. 2010 Feb; 17(2):371-6.
    View in: PubMed
    Score: 0.017
  4. Should suspected early gallbladder cancer be treated laparoscopically? J Gastrointest Surg. 2002 Jan-Feb; 6(1):50-6; discussion 56-7.
    View in: PubMed
    Score: 0.010
  5. Visceral artery aneurysm rupture. J Vasc Surg. 2001 Apr; 33(4):806-11.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.